6 Thalidomid er et dårligt substrat for cytochrom P450- isoenzymer, og derfor er klinisk vigtige interaktioner med lægemidler, der metaboliseres af dette enzymsystem, usandsynlige.
Thalidomide is a poor substrate for cytochrome P450 isoenzymes and therefore clinically important interactions with medicinal products metabolized by this enzyme system are unlikely.